Imaging-based classification of blood–brain barrier disruption in glioblastoma for patient selection in clinical trials: the NMN-BBB score
Nathalie L Albert, Roman Stürzl, Jonas Reis, Thomas Schabhüttl et autres
de, at (code pays fourni par la source)
2 citations
The Lancet Medical Imaging & Theranostics